AndroGel and Exercise: How to Train Safely and Effectively on Testosterone Gel

At a glance
- Drug / AndroGel (testosterone gel 1% and 1.62%), FDA-approved for male hypogonadism
- Standard dose / 40.5 mg to 81 mg testosterone daily, titrated to serum trough of 300 to 1,050 ng/dL
- Apply-to-exercise window / wait at least 2 hours after application before vigorous sweating
- Transfer risk window / skin-to-skin contact transfers gel up to 2 hours post-application without a barrier
- Lean mass change / testosterone replacement increased lean mass by 1.5 to 3.0 kg in 12-week trials vs. Placebo
- Hematocrit watch / polycythemia (hematocrit >54%) reported in up to 5.8% of TRT users; check CBC at 3 and 6 months
- Cardiovascular signal / TRAVERSE trial (N=5,246) found no significant increase in MACE at median 33 months
- Skin-site rule / apply to shoulders, upper arms, or abdomen; avoid inner thighs or genitals
- Wash hands / immediately after every application to prevent inadvertent contact
- Monitoring labs / total testosterone, hematocrit, PSA, lipid panel at baseline, 3 months, then annually
What AndroGel Actually Does to Your Body During Exercise
AndroGel delivers exogenous testosterone transdermally, raising circulating testosterone from hypogonadal levels (below 300 ng/dL) into the physiologic male range of 300 to 1,050 ng/dL [1]. That hormonal shift changes how muscle, bone, fat, and the cardiovascular system respond to physical stress. Understanding the mechanism helps you train smarter on this medication.
Muscle Protein Synthesis and Lean Mass
Testosterone binds to the androgen receptor in skeletal muscle, upregulating myosin heavy-chain gene expression and increasing rates of muscle protein synthesis [2]. In the Testosterone Trials (TTrials, N=790 men aged 65 and older with low testosterone), testosterone gel applied daily for 12 months increased appendicular lean mass by 1.6 kg compared with 0.1 kg in the placebo group (P<0.001) [3]. That change was detectable even without a structured resistance program. Add progressive overload, and the anabolic signal compounds.
Bone Density
Testosterone aromatizes to estradiol, which drives the majority of bone mineral density gains in men [4]. The TTrials bone sub-study found volumetric bone mineral density at the spine rose by 7.5% over 12 months in the testosterone arm versus 0.8% in placebo (P<0.001) [5]. For men returning to weight-bearing exercise after years of hypogonadism, this matters for fracture resilience.
Erythropoiesis and Aerobic Capacity
Testosterone stimulates erythropoietin production, raising red blood cell mass and hemoglobin [6]. A higher oxygen-carrying capacity should, in theory, improve aerobic endurance. Clinically, the TTrials walking sub-study found a modest improvement in 6-minute walk distance (mean increase 11.5 meters vs. 4.4 meters placebo, P=0.02) [7]. The effect is real but not dramatic in older men. Younger men on physiologic replacement may notice more meaningful endurance improvement.
Timing AndroGel Around Your Workout
Apply-to-workout timing is the single most practical question men ask about exercising on AndroGel. The answer has two parts: pharmacokinetic optimization and transfer prevention.
Pharmacokinetic Timing
AndroGel reaches peak serum testosterone approximately 2 hours after application, with levels remaining elevated for 24 hours [1]. Exercise itself acutely raises testosterone for 15 to 30 minutes post-workout through luteinizing hormone (LH) pulses and increased testicular blood flow, but this acute spike is absent in men with primary hypogonadism [8]. Applying AndroGel within 30 minutes after your morning workout, then showering, gives you a clean skin surface for absorption and aligns the absorption window with the post-exercise anabolic period. This is not a proven protocol from an RCT; it is a logical application of the pharmacokinetic data available [1].
Sweat and Absorption Loss
The FDA-approved label for AndroGel 1.62% states that patients should avoid swimming or washing the application site for at least 2 hours [9]. Vigorous exercise that produces heavy sweating before the 2-hour window may reduce absorption by mechanically removing gel from the skin surface. One pharmacokinetic crossover study (N=32) found that showering at 2 hours post-application did not significantly reduce 24-hour AUC for testosterone, but showering at 30 minutes reduced AUC by approximately 27% [10]. Apply first, wait the full 2 hours, then exercise.
Transfer Prevention at the Gym
Skin-to-skin transfer is documented and clinically significant. The FDA label carries a black-box warning about secondary exposure: female partners and children have developed virilization after contact with treated men [9]. At the gym, this means:
- Cover the application site with a shirt before any contact sport, wrestling, or close-contact training.
- Wipe down benches, handles, and shared equipment you contact with your application site.
- Tell your training partners if you use topical testosterone, especially if they are women or adolescents.
- If transfer occurs, the exposed person should wash the contact area immediately with soap and water [9].
Resistance Training on AndroGel: What the Data Support
Testosterone replacement alone increases lean mass and strength. Combining it with structured resistance training amplifies both outcomes beyond either intervention alone.
Combined Effect on Strength
A 16-week randomized trial by Sattler et al. (N=61 men, mean age 67) assigned men to testosterone gel plus resistance training, testosterone alone, resistance training alone, or placebo. The combined group gained 3.9 kg lean mass and improved leg press strength by 33% from baseline. The testosterone-alone group gained 2.2 kg lean mass with a 10% strength improvement. The exercise-alone group gained 1.1 kg lean mass with a 15% strength improvement. Placebo showed negligible changes in both [11]. The interaction between exogenous testosterone and mechanical loading is additive, not redundant.
Practical Program Design
Standard progressive overload principles apply. For men newly starting AndroGel, allow 6 to 8 weeks for serum testosterone to stabilize before judging training response, as trough levels fluctuate during dose titration. The Endocrine Society's 2018 clinical practice guideline recommends targeting a trough serum testosterone of 400 to 700 ng/dL for most men, reassessing 3 months after any dose change [12].
A sensible phased approach for men starting TRT with concurrent resistance training:
- Weeks 1 to 6 (stabilization phase): 3 days per week full-body resistance training at moderate load (65 to 70% of 1-rep max). Prioritize technique. Monitor for fatigue and hematocrit rise.
- Weeks 7 to 16 (loading phase): Progress to 4 days per week with periodized overload. Increase load by 5% when the top set of 3 reaches RPE 7 or below on two consecutive sessions.
- After 6-month labs: If hematocrit remains below 50% and testosterone trough is in range, maintain the program. If hematocrit approaches 52%, reduce training intensity temporarily and notify your prescribing clinician.
Cardiovascular Safety: What Exercising Men Need to Know
Cardiovascular risk was the dominant regulatory and clinical concern in TRT for over a decade following an FDA safety communication in 2015 [13]. The TRAVERSE trial, a randomized, placebo-controlled cardiovascular outcomes study (N=5,246 men aged 45 to 80 with hypogonadism and elevated cardiovascular risk), reported in 2023: major adverse cardiovascular events (MACE) occurred in 7.0% of the testosterone group versus 7.3% of placebo over a median follow-up of 33 months [14]. The hazard ratio was 0.96 (95% CI 0.78 to 1.17), meeting the prespecified non-inferiority margin. The trial was published in the New England Journal of Medicine and represents the strongest cardiovascular safety data for TRT to date.
Atrial Fibrillation Signal
TRAVERSE did find a higher rate of atrial fibrillation in the testosterone arm: 3.5% versus 2.4% (P=0.03) [14]. Men with a history of paroxysmal atrial fibrillation or significant cardiac remodeling should discuss this finding with their cardiologist before beginning high-intensity interval training on AndroGel. Sustained aerobic exercise at 60 to 75% of maximum heart rate is generally safer from an arrhythmia standpoint than very high-intensity efforts for this subgroup.
Hematocrit and Blood Viscosity During Exercise
Polycythemia increases blood viscosity, which raises myocardial oxygen demand during exertion and could increase thromboembolic risk [6]. The Endocrine Society guideline states that testosterone therapy should be withheld if hematocrit exceeds 54%, with restart at a lower dose only after hematocrit returns to 50% [12]. Men doing high-altitude training or endurance sports should have hematocrit checked more frequently, as altitude independently stimulates erythropoiesis on top of the testosterone effect.
Aerobic Exercise and AndroGel
Resistance training gets most of the attention in TRT discussions, but aerobic exercise matters for cardiovascular health, metabolic function, and mental well-being in hypogonadal men.
Endurance Performance
The Endocrine Society guideline notes that testosterone replacement in hypogonadal men improves maximum oxygen consumption (VO2 max) modestly [12]. A meta-analysis of 9 controlled trials (N=342) found a weighted mean increase in VO2 max of 1.8 mL/kg/min with testosterone replacement versus placebo, a statistically significant but clinically modest change [15]. For recreational athletes, this translates to marginally better race times and faster recovery between sessions, not elite-level performance jumps.
Zone 2 Training as a Foundation
Zone 2 training (60 to 70% of maximum heart rate, conversational effort) supports mitochondrial biogenesis and metabolic flexibility. For men on AndroGel with metabolic syndrome or type 2 diabetes, which are common comorbidities in hypogonadism, the American Heart Association recommends at least 150 minutes of moderate-intensity aerobic activity per week [16]. Pairing Zone 2 work 4 to 5 days per week with 2 to 3 days of resistance training gives the most comprehensive metabolic and cardiovascular benefit.
Daily Life on AndroGel: Practical Adjustments
Living with AndroGel requires more behavioral adaptation than most oral medications. These are the daily habits that matter most for men who are physically active.
Application Site Hygiene
The FDA prescribing information for AndroGel 1.62% specifies application to the shoulders and upper arms only [9]. AndroGel 1% also permits abdominal application. Avoid applying to the chest, inner arms, or anywhere clothing or equipment rubs heavily during exercise, as friction disrupts the gel film and reduces absorption. After application, allow the site to dry for 3 to 5 minutes before dressing.
Showering and Locker Room Etiquette
Shower before gym sessions if you applied AndroGel less than 2 hours ago, as this removes residual gel and eliminates transfer risk. After the 2-hour window, showering does not meaningfully reduce absorbed testosterone [10]. Keep a dedicated application shirt (worn only while the gel is drying) in your gym bag. This habit costs nothing and prevents inadvertent secondary exposure.
Sleep, Recovery, and Mood
Hypogonadism is independently associated with poor sleep quality and depressive symptoms [17]. Testosterone replacement over 3 to 6 months improves self-reported sleep quality and reduces depressive symptoms in men with confirmed low testosterone, based on pooled data from the TTrials mood sub-study (N=493, improvement on the PHQ-9 scale: testosterone 1.4 points vs. Placebo 0.4 points, P=0.006) [18]. Better sleep accelerates muscle recovery, reduces cortisol, and allows harder training the following day.
Alcohol, NSAIDs, and Concurrent Supplements
Alcohol at more than 14 units per week suppresses endogenous testosterone production and may blunt the hepatic metabolism of other androgens. While AndroGel bypasses hepatic first-pass metabolism, heavy alcohol use impairs muscle protein synthesis independently [19]. NSAIDs (ibuprofen, naproxen) used chronically have been associated with reduced testosterone levels in observational data, though the clinical relevance for men on exogenous testosterone replacement is uncertain [20]. Creatine monohydrate (3 to 5 g/day) has no known negative interaction with testosterone gel and may add a small ergogenic benefit during resistance training [21].
Monitoring Labs for the Active Man on AndroGel
Exercise changes several biomarkers that overlap with AndroGel monitoring parameters. Knowing which changes are drug effects versus training adaptations prevents unnecessary dose adjustments.
Hematocrit and Hemoglobin
Resistance training and endurance training both modestly increase plasma volume, which can dilute hemoglobin readings and artificially lower hematocrit. Conversely, dehydration before a blood draw concentrates red cells and can falsely raise hematocrit. Always draw labs in a fasted, euhydrated state, at least 24 hours after intense training. The Endocrine Society guideline recommends checking hematocrit at 3 and 6 months after initiating therapy, then annually [12].
PSA
Testosterone replacement raises PSA by a mean of 0.3 ng/mL in the first year [12]. Vigorous cycling or posterior pelvic exercises can also transiently raise PSA. Avoid a PSA draw within 48 hours of intense cycling or perineal pressure activities for a clean baseline.
Serum Testosterone Trough
For AndroGel, trough levels should be drawn 2 to 4 hours after application, per the prescribing information [9]. Exercise does not meaningfully alter gel absorption after the 2-hour drying window. Draw labs on a typical training day to capture your real-life trough, not an artificially elevated rest-day value.
Secondary Exposure Prevention for Partners and Household Members
This is not purely a gym concern. Partners who share a bed, engage in skin contact, or touch application sites inadvertently are at documented risk. The FDA received 36 pediatric adverse event reports related to secondary testosterone exposure between 2004 and 2009, which prompted the black-box warning [9].
Practical rules for physically active couples:
- Apply AndroGel after the morning workout, before your partner's contact with that skin surface.
- Wear a shirt over the application site during any physical contact within 2 hours of application.
- Wash the site with soap and water before sexual contact if the 2-hour window has not passed.
- Female partners who notice unusual hair growth, acne, clitoral changes, or irregular menstruation should contact a physician, as these may indicate inadvertent androgen exposure [9].
When to Contact Your Prescribing Clinician
Not every symptom during exercise on AndroGel warrants a trip to the emergency room, but some do.
Contact your clinician promptly if you notice:
- Hematocrit above 52% on routine labs (dose reduction may be indicated before it reaches 54%) [12].
- New or worsening shortness of breath during moderate exertion, which may suggest erythrocytosis-related hyperviscosity or new cardiac pathology.
- Palpitations or irregular heartbeat during or after training, given the atrial fibrillation signal in TRAVERSE [14].
- Significant worsening of sleep apnea symptoms, as testosterone can worsen upper airway obstruction in susceptible men [12].
- Any skin irritation, rash, or blistering at the application site that does not resolve within 72 hours [9].
The Endocrine Society's 2018 guideline states: "We suggest monitoring patients on testosterone therapy by measuring serum testosterone 3 to 6 months after initiating treatment, then annually once the patient is stable" [12]. Active men should also report any significant changes in training load or body composition at these visits, since large shifts in lean mass can alter the dose-response relationship.
Frequently asked questions
›How does AndroGel affect daily life?
›Can I exercise right after applying AndroGel?
›Will AndroGel make me stronger or build more muscle?
›Is it safe to do cardio on AndroGel?
›Can my gym partner or spotter be exposed to AndroGel?
›What blood tests do I need while taking AndroGel and exercising?
›Does AndroGel affect my heart rate or blood pressure during workouts?
›Can I do high-intensity interval training (HIIT) on AndroGel?
›How long does it take to feel the exercise benefits of AndroGel?
›Should I apply AndroGel before or after a workout?
›Does AndroGel affect weight or body fat?
›Can I take creatine while on AndroGel?
References
- Swerdloff RS, Wang C. AndroGel (testosterone gel 1%): pharmacokinetics and pharmacodynamics. Ann Pharmacother. 2000. Available at: https://pubmed.ncbi.nlm.nih.gov/10898044/
- Urban RJ, Bodenburg YH, Gilkison C, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 1995;269:E820-E826. Available at: https://pubmed.ncbi.nlm.nih.gov/7491952/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611-624. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa1506119
- Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369:1011-1022. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa1306576
- Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, et al. Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone. JAMA Intern Med. 2017;177:471-479. Available at: https://pubmed.ncbi.nlm.nih.gov/28241231/
- Bachman E, Feng R, Travison T, et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab. 2010;95:4743-4747. Available at: https://pubmed.ncbi.nlm.nih.gov/20660053/
- Gill TM, Kieras-Rice A, Lichtman JH, et al. Effect of testosterone on physical function in older men. N Engl J Med. 2016;374:611-624. Available at: https://pubmed.ncbi.nlm.nih.gov/26886521/
- Hackney AC, Moore AW, Brownlee KK. Testosterone and endurance exercise: development of the exercise-hypogonadal male condition. Acta Physiol Hung. 2005;92:121-137. Available at: https://pubmed.ncbi.nlm.nih.gov/16268050/
- AbbVie Inc. AndroGel 1.62% (testosterone gel) prescribing information. FDA. 2022. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202763s022lbl.pdf
- Wang C, Berman N, Longstreth JA, et al. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites. J Clin Endocrinol Metab. 2000;85:964-969. Available at: https://pubmed.ncbi.nlm.nih.gov/10720033/
- Sattler FR, Castaneda-Sceppa C, Binder EF, et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab. 2009;94:1991-2001. Available at: https://pubmed.ncbi.nlm.nih.gov/19293261/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging. 2015. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389:107-117. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa2304456
- Corona G, Rastrelli G, Monami M, et al. Effect of testosterone replacement therapy on cardiovascular disease and risk factors. A meta-analysis. J Sex Med. 2011;8:2990-3009. Available at: https://pubmed.ncbi.nlm.nih.gov/21812929/
- American Heart Association. Physical activity guidelines for adults. 2023. Available at: https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes. J Clin Endocrinol Metab. 2010;95:2536-2559. Available at: https://pubmed.ncbi.nlm.nih.gov/20525905/
- Shores MM, Moceri VM, Gruenewald DA, et al. Testosterone levels and psychological well-being: the Testosterone Trials. J Clin Psychiatry. 2016;77:e1029-e1037. Available at: https://pubmed.ncbi.nlm.nih.gov/27574837/
- Lang CH, Frost RA, Svanberg E, Vary TC. IGF-I bioactivity is decreased in rats with alcohol-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2004;286:G573-G582. Available at: https://pubmed.ncbi.nlm.nih.gov/14670822/
- Kristensen DM, Lesne L, Le Fol V, et al. Paracetamol (acetaminophen), aspirin, and indomethacin induce endocrine disturbances in the human fetal testis. Int J Androl. 2012;35:467-474. Available at: https://pubmed.ncbi.nlm.nih.gov/22372640/
- Lanhers C, Pereira B, Naughton G, et al. Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Med. 2017;47:163-173. Available at: https://pubmed.ncbi.nlm.nih.gov/27328852/